Short-Term Rosuvastatin Therapy for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Diabetes and Chronic Kidney Disease

Study Questions:

What is the safety and efficacy of rosuvastatin in preventing contrast-induced acute kidney injury (CIAKI) in patients with diabetes mellitus (DM) and chronic kidney disease (CKD)?